Type : |
Journal |
Internet-link : |
https://doi.org/10.1007/s40268-023-00433-7 |
|
Forskerhold : |
Incheon - Quality Evaluation Team, Samsung Bioepis Co |
Forfattere : |
Tak M, Jeong H, Yun J, Kim J, Kim S, Lee Y, Park S-J. |
Titel : |
In‑Use Stability of SB12 (Eculizumab, Soliris Biosimilar) Diluted in Saline and Dextrose Infusion Solution after an Extended Storage Period. |
Nummer : |
Drugs R D ;23,4:363 - 375 2023 |
|
Cotationvaleur : |
|
Fysisk stabilitet : |
|
Kemisk stabilitet : |
|
Andre metoder : |
|
Kommentarer : |
Proteiner: biologisk aktivitet ved enzymatisk teknik |
|
Lister
Eculizumab
|
|
|
|
|
|
|
|
|
|
5 mg/ml |
2-8°C |
|
90 |
|
|
|
|
|
|
5 mg/ml |
28-32°C |
|
72 |
|
|
|
|
|
|
5 mg/ml |
2-8°C |
|
90 |
|
|
|
|
|
|
5 mg/ml |
28-32°C |
|
72 |
|
|
|
|
|
|
5 mg/ml |
2-8°C |
|
90 |
|
|
|
|
|
|
5 mg/ml |
28-32°C |
|
72 |
|
|
|
|
|
|
5 mg/ml |
2-8°C |
|
90 |
|
|
|
|
|
|
5 mg/ml |
28-32°C |
|
72 |
|
|
|
|
|